Caplin Point Laboratories Ltd

NSE: CAPLIPOINT · BSE: 524742 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹2,835.10
Market cap: ₹21,550 Cr
Revenue (annual): ₹2,187 Cr
Net profit (annual): ₹641.2 Cr
P/E (TTM): 32.4×Sector 50.4×
Promoter holding: 70.57%+0.00% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Price Movement Clarification 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

25 Sep 2026 15:27 IST BSE

Annual General Meeting

Caplin Point Laboratories Annual General Meeting

Caplin Point Laboratories concluded its 35th Annual General Meeting on September 25, 2026. Key business included adopting financial statements and approving the final dividend declaration.

Read the filing ↗